Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Solventum Corporation Common Stock (NY:SOLV)

73.51 +1.42 (+1.97%)
Streaming Delayed Price Updated: 2:05 PM EDT, Aug 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Solventum Corporation Common Stock

< Previous 1 2 3 4 5 Next >
SOLV Q2 Deep Dive: Product Launches and Execution Drive Outperformance Amid Margin Pressures
Healthcare solutions provider Solventum (NYSE:SOLV) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 3.8% year on year to $2.16 billion. Its non-GAAP profit of $1.69 per... 
Via StockStory
Topics World Trade
Which S&P500 stocks are moving on Monday?
Let's have a look at what is happening on the US markets one hour before the close of the markets on Monday. Below you can find the top S&P500 gainers and losers in today's session. 
Via Chartmill
3 Mid-Cap Stocks We Keep Off Our Radar
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from... 
Via StockStory
Earnings Scheduled For August 7, 2025
 
Via Benzinga
Forecasting The Future: 3 Analyst Projections For Solventum
 
Via Benzinga
Solventum (SOLV) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings World Trade
Solventum (SOLV) Fiscal Q2 EPS Jumps 8%
Via The Motley Fool
Topics Economy World Trade
Movers and shakers in today's after-hours session for S&P500 stocks?
Wondering what's happening in today's after-hours session with S&P500 stocks? Stay tuned for the latest updates on movers and shakers. 
Via Chartmill
Solventum Corp (NYSE:SOLV) Reports Mixed Q2 2025 Earnings with Strong EPS Beat and Slight Revenue Miss
Solventum Corp (NYSE:SOLV) reported mixed Q2 2025 earnings, beating EPS estimates at $1.69 but slightly missing revenue forecasts. Shares rose 3% post-announcement. 
Via Chartmill
Solventum’s (NYSE:SOLV) Q2: Beats On Revenue
Healthcare solutions provider Solventum (NYSE:SOLV) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 3.8% year on year to $2.16 billion. Its non-GAAP profit of $1.69 per share was... 
Via StockStory
Solventum (SOLV) Reports Earnings Tomorrow: What To Expect
Healthcare solutions provider Solventum (NYSE:SOLV) will be announcing earnings results this Thursday afternoon. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence World Trade
ZimVie Doubles — And Then Some — On Its Second Takeover Deal
The Zimmer Biomet spinoff is looking to head for private waters under the fund Archimed. 
Via Investor's Business Daily
3 Cash-Producing Stocks with Questionable Fundamentals
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak... 
Via StockStory
Tandem Diabetes, Solventum, LeMaitre, UFP Technologies, and Artivion Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. The wider market sentiment turned... 
Via StockStory
Topics ETFs Stocks World Trade
1 Value Stock for Long-Term Investors and 2 to Approach with Caution
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are... 
Via StockStory
3 Mid-Cap Stocks with Questionable Fundamentals
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from... 
Via StockStory
3 Low-Volatility Stocks Facing Headwinds
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere. 
Via StockStory
SOLVENTUM CORP (NYSE:SOLV) - A Strong Technical Setup for Breakout Investors
SOLVENTUM CORP (NYSE:SOLV) shows strong technicals and a high-quality setup, making it a breakout candidate for traders. The stock has outperformed 83% of the market and presents clear support levels. 
Via Chartmill
SOLV Q1 Earnings Call: Margin Headwinds Offset by Volume Growth and Product Momentum
Healthcare solutions provider Solventum (NYSE:SOLV) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 2.7% year on year to $2.07 billion. Its non-GAAP profit of... 
Via StockStory
Topics Economy World Trade
Q1 Rundown: Solventum (NYSE:SOLV) Vs Other Surgical Equipment & Consumables - Diversified Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at Solventum (NYSE:SOLV) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy
3 Healthcare Stocks Skating on Thin Ice
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of... 
Via StockStory
Topics Stocks
2 Profitable Stocks Worth Investigating and 1 to Be Wary Of
A company with profits isn’t always a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential. 
Via StockStory
Firing on All Cylinders: CONMED (NYSE:CNMD) Q1 Earnings Lead the Way
Looking back on surgical equipment & consumables - diversified stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including CONMED (NYSE:CNMD) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy
Assessing Solventum: Insights From 9 Financial Analysts
 
Via Benzinga
What's going on in today's session: S&P500 movers
Curious about the top performers within the S&P500 index in the middle of the day on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview. 
Via Chartmill
Which S&P500 stocks are gapping on Wednesday?
Looking for the S&P500 stocks that are experiencing notable gaps on Wednesday? Find out which stocks are gapping up and gapping down in the S&P500 index during today's session. 
Via Chartmill
3 of Wall Street’s Favorite Stocks Walking a Fine Line
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because... 
Via StockStory
Topics Economy
Solventum, Envista, ICU Medical, Globus Medical, and Enovis Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides... 
Via StockStory
Topics Government Stocks World Trade
Stay informed with the top movers within the S&P500 index on Friday.
Get insights into the S&P500 index performance on Friday. Explore the top gainers and losers within the S&P500 index in today's session. 
Via Chartmill
What's going on in today's session: S&P500 movers
Let's delve into the developments on the US markets in the middle of the day on Friday. Below, you'll find the top gainers and losers within the S&P500 index during today's session. 
Via Chartmill
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.